What is Jefferies's price target for PM?

Jefferies's latest stated price target for Philip Morris International Inc (PM) is $180, from its action on Jan 20, 2026.

What is Jefferies's rating on PM?

Jefferies rates PM Hold, a neutral rating, as of Jan 20, 2026.

When did Jefferies last change its view on PM?

On Jan 20, 2026, Jefferies downgrades to Hold from Buy, price target $180.

Analyst firms · Jefferies · PM

Jefferies PM price target and rating history

Philip Morris International Inc (PM) · Health Care

Jefferies rates Philip Morris International Inc (PM) Hold with a $180 price target, as of its latest action on Jan 20, 2026. It has published 3 rating actions on PM since January 2023, including 1 upgrade and 1 downgrade.

Current rating: Hold
Price target: $180
Median target, all firms: Too few
Actions on PM: 3

Jefferies price target on PM

Jefferies price target on PM, each point a stated target, January 2023 to January 2026.

Every Jefferies rating on PM

Jan 20, 2026
DowngradeJefferies downgrades to Hold from Buy, price target $180
Jul 9, 2025
ResumeJefferies resumes coverage at Buy, price target $220
Jan 19, 2023
UpgradeJefferies upgrades to Buy from Hold, price target $86 to $118

How other firms rate PM

Each firm's latest rating and stated target in the last 12 months.

Firm	Rating	Price target	Date
BTIG	Buy	$216	Jul 22, 2026
Jefferies	Hold	$180	Jan 20, 2026

Questions about Jefferies and PM

What is Jefferies's price target for PM?: Jefferies's latest stated price target for Philip Morris International Inc (PM) is $180, from its action on Jan 20, 2026.
What is Jefferies's rating on PM?: Jefferies rates PM Hold, a neutral rating, as of Jan 20, 2026.
When did Jefferies last change its view on PM?: On Jan 20, 2026, Jefferies downgrades to Hold from Buy, price target $180.

More PM rating histories

All Jefferies ratings PM news and filings Every analyst firm

From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.